Ethylamphetamine
From Wikipedia, the free encyclopedia
Ethylamphetamine
|
|
Systematic (IUPAC) name | |
N-ethyl-1-phenyl-propan-2-amine | |
Identifiers | |
CAS number | |
ATC code | ? |
PubChem | |
Chemical data | |
Formula | C11H17N |
Mol. mass | 163.259 g/mol |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | hepatic |
Half life | ? |
Excretion | renal |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | oral, intravenous, smoked, insufflated |
N-ethylamphetamine (Etilamfetamine, Apetinil) is a stimulant drug derived from amphetamine which was invented in the early 1900s.
Ethylamphetamine was used as an appetite suppressant in the 1950s[1] but was not as commonly used as other amphetamine derivatives such as dextroamphetamine or benzphetamine, and went out of fashion once newer drugs such as phenmetrazine were introduced.
Ethylamphetamine is intermediate between amphetamine and methamphetamine in potency, and is self-administered by animals;[2] concerns about its abuse potential were a likely factor that it was not so widely used as other similar drugs. Ethylamphetamine is still encountered as a drug of abuse on the black market, but is very uncommon.
Dosage (oral) tends to fall somewhere between 10 and 30 milligrams.
[edit] See also
[edit] References
- ^ Junet R. Ethylamphetamine in the treatment of obesity. Praxis. 1956 Oct 25;45(43):986-8. (French)
- ^ Woolverton WL, Shybut G, Johanson CE. Structure-activity relationships among some d-N-alkylated amphetamines. Pharmacology Biochemistry and Behavior. 1980 Dec;13(6):869-76.
|